Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
International Psychogeriatrics|August 3, 2013
Incidence of dementia: evidence for an effect modification by gender. The ILSA StudyMarianna Noale, Federica Limongi, Sabina Zambon, et al.Current Atherosclerosis Reports|October 3, 2020
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein ReductionAlberto Zambon, Angela Pirillo, Sabina Zambon, et al.Ultrasound in Medicine & Biology|May 1, 2012
Quantitative ultrasound criteria for risk stratification in clinical practice: a comparative assessmentMarianna Noale, Stefania Maggi, Stefano Gonnelli, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Focus on lipoprotein(a)Marta Biolo, Camilla Portinari, Camilla Goffi, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2016
Activity of myricetin and other plant-derived polyhydroxyl compounds in human LDL and human vascular endothelial cells against oxidative stressRiccardo Bertin, Zheng Chen, Raffaella Marin, et al.Plos One|September 20, 2021
Tooth retention predicts good physical performance in older adultsEstella Musacchio, Pierluigi Binotto, Egle Perissinotto, et al.Diabetes/Metabolism Research and Reviews|November 26, 2005
Plasma fatty acids and lipoproteins in type 2 diabetic patientsAnnunziata Lapolla, Giovanni Sartore, Giovanni Roselli Della Rovere, et al.Aging Clinical and Experimental Research|July 5, 2003
Cognitive functions are not affected by dietary fatty acids in elderly subjects in the Pro.V.A. study populationEnzo Manzato, Giovanni Roselli della Rovere, Sabina Zambon, et al.Obesity Surgery|September 10, 2008
Bariatric surgery improves atherogenic LDL profile by triglyceride reductionSabina Zambon, Giovanna Romanato, Giovanni Sartore, et al.Current Atherosclerosis Reports|July 18, 2025
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?Marta Biolo, Federica Galimberti, Camilla Portinari, et al.Pageof 8